BioLab Sciences, an innovator in regenerative medicine technologies, has announced the patent of MyOwn SkinTM, a new, non-evasive, regenerative tissue therapy that uses a patient’s own skin to accelerate the healing of chronic wounds, burns, diabetic foot ulcers and other difficult-to-heal wounds.Read More
The FDA has approved a wound retraction system created by Prescient Surgical. The company’s CleanCision wound retraction and protection system is a sterile, single-use irrigating wound device that integrates surgical retraction, wound barrier protection, and fluid delivery and removal to protect against surgical site infections (SSIs).
Read more here.Read More
Ohio State University Wexner Medical Center researchers have created electrically charged bandages that can combat antibiotic resistance, enable healing in burn wounds, and help prevent infections. When the dressing comes in contact with bodily fluids it becomes electrically activated.Read More
Findings from a randomized controlled trial revealed that patients with a diabetic foot ulcer, who received probiotic supplementation for 12 weeks, experienced faster wound healing coupled with an improved glycemic and lipid profile compared with patients assigned a placebo. Read more.
via HealioRead More
Ashwinraj Karthikeyan, a student in UVA’s School of Engineering and Applied Science, presented his invention, Phoenix-Aid – a new type of five-layered wound care technology set to revolutionize how chronic wounds are treated in developing countries and impoverished areas around the world, at the Collegiate Inventors Competition in November. Read more.
pc: Dan Addison, University Communications, UVARead More
Jitka Petrlova at Lund University, Sweden, together with Peter Bond’s team at the A*STAR Bioinformatics Institute, has discovered a strategy that the body uses to neutralize invading microbes. This finding is a critical development in fighting bacteria in skin wounds. Read more.Read More
Skin damage associated with moisture and pressure
- Identify how wounds are classified according to wound depth and etiology.
- Describe the etiology of a pressure injury (PI) and incontinence-associated skin damage (IAD).
- Discuss evidence-based protocols of care of prevention and management if IAD and PIs.
- Describe the NPUAP-EPUAP Pressure Injury Classification System.
- Identify appropriate products that can be used for preventioin and treatment of IAD and PIs.
Submit below to view the Webinar and download Slidedeck
*By downloading this (product) you are opting in to receiving information from Healthcom Media and Affiliates. Or the details, including your email address/mobile number, may be used to keep you informed about future products and services.Read More
Introduction: Deep sternal wound infections (DSWIs) are rare but devastating complication after median sternotomy following cardiac surgery. Especially in the presence of artificial material or inadequate preliminary muscle flaps, the pedicled omentum flap is due to its immunological properties, the predetermined flap in salvage procedures. (more…)Read More
A new study shows a clear association between the prophylactic use of five-layer foam sacral dressings and reductions in pressure injury rates. Specifically, the study looked at the prophylactic use of Mölnlycke’s Mepilex® Border Sacrum dressing in the acute care setting over a six-year period (2010-2015). (more…)Read More
Many cancer patients, especially those who’ve undergone breast cancer treatment, experience painful, swollen limbs, a condition called lymphedema.
Now researchers say they’ve found an underlying mechanism that could eventually lead to the first drug therapy for the debilitating condition. (more…)Read More
Investigators at the University of California in San Francisco are recruiting people with MS for an international study of the gut microbiome – the population of bacteria in the gut – in MS. They are seeking people with primary progressive MS nationwide (there is no need for onsite visits), as well as people with any other type of MS who can make a one-time visit to San Francisco, New York, Boston or Pittsburgh. The overall purpose of these studies is to investigate the potential role of gut bacteria in MS.